Hemoglobin-Vesicle, a Cellular Artificial Oxygen Carrier that Fulfils the Physiological Roles of the Red Blood Cell Structure

  • Hiromi Sakai
  • Keitaro Sou
  • Hirohisa Horinouchi
  • Koichi Kobayashi
  • Eishun Tsuchida
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 662)


Hb-vesicles (HbV) are artificial O2 carriers encapsulating concentrated Hb solution (35 g/dL) with a phospholipid bilayer membrane (liposome). The concentration of the HbV suspension is extremely high ([Hb] = 10 g/dL) and it has an O2 carrying capacity that is comparable to that of blood. HbV is much smaller than RBC (250 vs. 8000 nm), but it recreates the functions of RBCs; (i) the slower rate of O2 unloading than Hb solution; (ii) colloid osmotic pressure is zero; (iii) the viscosity of a HbV suspension is adjustable to that of blood; (iv) HbV is finally captured by and degraded in RES; (v) co-encapsulation of an allosteric effector to regulate O2 affinity; (vi) the lipid bilayer membrane prevents direct contact of Hb and vasculature; (vii) NO-binding is retarded to some extent by an intracellular diffusion barrier, and HbV does not induce vasoconstriction. (viii) Both RBC and HbV can be a carrier of not only O2 but also exogenous CO. However, HbV has limitations such as a shorter functional half-life when compared with RBCs. On the other hand, the advantages of HbV are that it is pathogen-free and blood-type-antigen-free; moreover, it can withstand long-term storage of a few years, none of which can be achieved by the RBC transfusion systems.


Hemorrhagic Shock Oxygen Carrier Colloid Osmotic Pressure Plasma Substitute Phospholipid Bilayer Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work is supported by Health and Labour Sciences Research Grants (Health Science Research Including Drug Innovation), Ministry of Health, Labour and Welfare, Japan (H.S. H.H, E.T, K.K.), and Grants in Aid for Scientific Research from the Japan Society for the Promotion of Science (B19300164) (H.S.).


  1. 1.
    Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. (2008) Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 263:4–15.PubMedGoogle Scholar
  2. 2.
    Sakai H, Okamoto M, Ikeda E, Horinouchi H, Kobayashi K, Tsuchida E. (2009) J Biomed Mater Res A 90:1107–1119.Google Scholar
  3. 3.
    Sakai H, Tomiyama KI, Sou K, Takeoka S, Tsuchida E. (2000) Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug Chem 11:425–432PubMedCrossRefGoogle Scholar
  4. 4.
    Sakai H, Horinouchi H, Tomiyama K, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E. (2001) Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 159:1079–1088.PubMedCrossRefGoogle Scholar
  5. 5.
    Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S, Suematsu M, Takaori M, Kobayashi K, Tsuchida E. (2004) Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther 311:874–884.PubMedCrossRefGoogle Scholar
  6. 6.
    Sakai H, Yuasa M, Onuma H, Takeoka S, Tsuchida E. (2000) Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types. Bioconjug Chem 11:56–64.PubMedCrossRefGoogle Scholar
  7. 7.
    Vandegriff KD, McCarthy M, Rohlfs RJ, Winslow RM. (1997) Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated. Biophys Chem 69:23–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Sakai H, Sato A, Takeoka S, Tsuchida E. (2007) Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions. Langmuir 23:8121–8128.PubMedCrossRefGoogle Scholar
  9. 9.
    Sakai H, Suzuki Y, Kinoshita M, Takeoka S, Maeda N, Tsuchida E. (2003) O2 release from Hb vesicles evaluated using an artificial, narrow O2-permeable tube: comparison with RBCs and acellular Hbs. Am J Physiol Heart Circ Physiol 285:H2543–H2551PubMedGoogle Scholar
  10. 10.
    Sakai H, Sato A, Masuda K, Takeoka S, Tsuchida E. (2008) Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier. J Biol Chem 283:1508–1517PubMedCrossRefGoogle Scholar
  11. 11.
    Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E. (2004) Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 32:539–545.PubMedCrossRefGoogle Scholar
  12. 12.
    Sakai H, Horinouchi H, Tsuchida E, Kobayashi K. (2009) Hemoglobin-vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation from hemorrhagic shock in a rat model. Shock 31(5):507–514.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Hiromi Sakai
    • 1
  • Keitaro Sou
    • 1
  • Hirohisa Horinouchi
    • 2
  • Koichi Kobayashi
    • 2
  • Eishun Tsuchida
    • 1
  1. 1.Research Institute for Science and EngineeringWaseda UniversityTokyoJapan
  2. 2.Department of SurgerySchool of Medicine, Keio UniversityTokyoJapan

Personalised recommendations